🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.8200
-0.0185 (-2.21%)
Nov 19, 2026, 4:00 PM EST - Market closed

Lineage Cell Therapeutics Revenue

Lineage Cell Therapeutics had revenue of $1.43M in the quarter ending September 30, 2026, a decrease of -61.04%. This brings the company's total for the last twelve months to $10.84M, up 0.18% year-over-year. In the year 2025, Lineage Cell Therapeutics had annual revenue of $14.56M with 53.24% growth. That makes Lineage Cell Therapeutics the 37,030th largest company in the world by revenue and 4,843rd in the United States.

Revenue (ttm)
$10.84M
Revenue Growth
+0.18%
P/S Ratio
19.31
Revenue / Employee
$140,727
Employees
77
Market Cap
209.23M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.56M5.06M53.24%
Dec 31, 20249.50M554.00K6.19%
Dec 31, 20238.95M-5.76M-39.16%
Dec 31, 202214.70M10.36M238.70%
Dec 31, 20214.34M2.52M137.73%
Dec 31, 20201.83M-1.69M-48.05%
Dec 31, 20193.52M-1.47M-29.53%
Dec 31, 20184.99M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 20141.22M-3.21M-72.40%
Dec 31, 20134.43M518.67K13.25%
Dec 31, 20123.92M-4.87M-55.45%
Dec 31, 20118.79M1.40M18.96%
Dec 31, 20107.39M5.46M283.78%
Dec 31, 20091.93M421.38K28.02%
Dec 31, 20081.50M457.67K43.75%
Dec 31, 20071.05M142.92K15.82%
Dec 31, 2005903.20K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.